一种糖溶性代谢物绕过BRCA2的"双击"瘤抑制
Li Ren Kong1, Komal Gupta2, Andy Jialun Wu3
1Cancer Science Institute of Singapore, Singapore 117599, Singapore; NUS Centre for Cancer Research (N2CR), National University of Singapore, Singapore 117599, Singapore; MRC Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK; Department of Pharmacology, National University of Singapore, Singapore 117600, Singapore.
Cell
|April 12, 2024
概括
甲基醇 (MGO) 暂时禁用BRCA2,绕过了双击癌症模型. 这种代谢机制将MGO与癌症发展中的特定突变特征联系起来.
科学领域:
- 生物化学
- 遗传学
- 癌症学
背景情况:
- 克努森的"双击"模式描述了癌症需要瘤抑制基因副本的失活.
- BRCA2是一种关键的乳腺癌抑制蛋白,参与DNA修复.
研究的目的:
- 调查甲基素 (MGO) 在癌症发展中的作用,超出"双击"模式.
- 探索MGO对BRCA2的暂时失活及其与突变特征的联系.
主要方法:
- 对非恶性乳腺细胞和来自患者的器官进行分析.
- 在Kras驱动的小鼠胰腺癌和人类乳腺癌中研究MGO积累和DNA损伤.
- 评估BRCA2蛋白质分解和功能性基缺陷.
主要成果:
- 在没有双基性失活的情况下,MGO暂时失活BRCA2,导致单基替代 (SBS) 签名.
- 基因单基因BRCA2突变导致MGO诱导的SBS特征.
- 间歇性MGO暴露导致没有永久的BRCA2损失的偶发性突变.
结论:
- 由MGO诱导的BRCA2单双缺陷提供了一种代谢机制,可以绕过Knudson的双击要求.
- 这种途径将代谢失调 (例如,糖解激活) 与癌症相关的突变特征联系起来.
- 这些发现表明新陈代谢与癌症演变之间通过短暂的瘤抑制器失活存在新的联系.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


